Eberhard Kopetzki

Title: Eberhard Kopetzki - Innovator in Diagnostic Technologies

Introduction

Eberhard Kopetzki, based in Penzberg, Germany, is a notable inventor recognized for his contributions to the field of diagnostics. With a focus on enhancing analytical methodologies, he has made significant strides in biochemistry through his innovative approaches.

Latest Patents

Kopetzki holds a patent for "Recombinant inactive core streptavidin mutants." This invention pertains to muteins of avidin and streptavidin exhibiting reduced binding affinity for biotin. The primary application of this invention is to serve as interference elimination reagents in diagnostic tests, such as immunoassays and nucleic acid hybridization assays. Furthermore, the muteins are utilized as regenerative systems for binding biotin, facilitating the analysis of biotinylated molecules and investigating receptor-ligand interactions, in addition to the affinity purification of biotinylated substances.

Career Highlights

Eberhard Kopetzki continues his work at Roche Diagnostics GmbH, a leading company in the field of in-vitro diagnostics. His role at Roche has allowed him to operate at the forefront of innovation, driving advancements in diagnostic testing technologies.

Collaborations

Throughout his career, Kopetzki has collaborated with esteemed colleagues, including Rainer Müller and Richard Engh. Together, they have contributed to enhancing and developing innovative solutions in their fields of expertise.

Conclusion

Eberhard Kopetzki's inventive spirit and dedication to improving diagnostic methods have left a lasting impact on the industry. His key patent reflects his commitment to advancing the science of diagnostics, while his collaboration with notable colleagues further amplifies the potential for future innovations.